Cyclerion Announces CY6463 Clinical Pipeline Progress and Second Quarter 2022 Financial Results

Go back to Cyclerion Announces CY6463 Clinical Pipeline Progress and Second Quarter 2022 Financial Results
(NASDAQ: CYCN) Delayed: 3.59 +0.01 (0.28%)
Previous Close $3.58    52 Week High
Open $3.56    52 Week Low
Day High $3.59    P/E N/A 
Day Low $3.56    EPS
Volume 1,527